Cargando…

Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma

Altered metabolism is an emerging hallmark of cancer. Cancer cells preferentially utilize glycolysis for energy production, termed “aerobic glycolysis.” In this study, we performed a comprehensive analysis of the glycolytic activity in head and neck squamous cell carcinoma (HNSCC) using data obtaine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Hideyuki, Kawabata-Iwakawa, Reika, Ida, Shota, Mito, Ikko, Tada, Hiroe, Chikamatsu, Kazuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423753/ https://www.ncbi.nlm.nih.gov/pubmed/34493792 http://dx.doi.org/10.1038/s41598-021-97292-6

Ejemplares similares

Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
por: Mito, Ikko, et al.
Publicado: (2021)

Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma
por: Tada, Hiroe, et al.
Publicado: (2020)

Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy
por: Takahashi, Hideyuki, et al.
Publicado: (2016)

AKT3 is a key regulator of head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Establishment of Synergistic Chemoimmunotherapy for Head and Neck Cancer Using Peritumoral Immature Dendritic Cell Injections and Low-Dose Chemotherapies
por: Ishii, Hiroki, et al.
Publicado: (2017)

Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
por: Elmusrati, Areeg, et al.
Publicado: (2021)

Carbon‐ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational study
por: Takayasu, Yukihiro, et al.
Publicado: (2019)

Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas
por: Kirtane, Kedar, et al.
Publicado: (2022)

Prospective observational study of carbon‐ion radiotherapy for non‐squamous cell carcinoma of the head and neck
por: Shirai, Katsuyuki, et al.
Publicado: (2017)

Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma
por: Sakakura, Koichi, et al.
Publicado: (2015)

In vitro assessment of antitumor immune responses using tumor antigen proteins produced by transgenic silkworms
por: Yamada, Kanae, et al.
Publicado: (2021)

Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis
por: Wang, Yanting, et al.
Publicado: (2021)

Identification of Prognostic Markers for Head and NeckSquamous Cell Carcinoma Based on Glycolysis-Related Genes
por: Ren, Xiaobin, et al.
Publicado: (2022)

HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma
por: Zhang, Hongbo, et al.
Publicado: (2022)

Mechanisms of immune evasion by head and neck cancer stem cells
por: Xavier, Flávia Caló Aquino, et al.
Publicado: (2022)

Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma
por: Li, Jing, et al.
Publicado: (2022)

Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis
por: Shiga, Kiyoto, et al.
Publicado: (2015)

Plac1 Remodels the Tumor Immune Evasion Microenvironment and Predicts Therapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Meng, Xiaoyan, et al.
Publicado: (2022)

Functional and T Cell Receptor Gene Usage Analysis of Cytotoxic T Lymphocytes in Fresh Tumor‐infiltrating Lymphocytes from Human Head and Neck Cancer
por: Chikamatsu, Kazuaki, et al.
Publicado: (1995)

Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma
por: Li, Hui-Min, et al.
Publicado: (2017)

A Novel Prognostic Index Based on the Analysis of Glycolysis-Related Genes in Head and Neck Squamous Cell Carcinomas
por: Liu, Yuchao, et al.
Publicado: (2020)

Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Analysis of T Cell Receptor Variability in Fresh Tumor‐infiltrating Lymphocytes from Human Head and Neck Cancer
por: Chikamatsu, Kazuaki, et al.
Publicado: (1994)

Fascin upregulation in primary head and neck squamous cell carcinoma is associated with lymphatic metastasis
por: PAPASPYROU, KONSTANTINOS, et al.
Publicado: (2014)

Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon‐ion radiotherapy
por: Musha, Atsushi, et al.
Publicado: (2023)

An update on angiogenesis targeting in head and neck squamous cell carcinoma
por: Micaily, Ida, et al.
Publicado: (2020)

Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
por: Bilguun, Erkhem-Ochir, et al.
Publicado: (2020)

Upregulated YTHDF1 associates with tumor immune microenvironment in head and neck squamous cell carcinomas
por: Huang, Yongsheng, et al.
Publicado: (2022)

Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma
por: Zhang, Xiao-Yun, et al.
Publicado: (2014)

Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma
por: Chen, LangXiong, et al.
Publicado: (2021)

The let-7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PD-L1 degradation
por: Yu, Dan, et al.
Publicado: (2019)

Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis
por: Maaser, K, et al.
Publicado: (2003)

Upregulation of KHDC1L promotes the proliferation and inhibits apoptosis in head and neck squamous cell carcinoma
por: Zhang, Qi, et al.
Publicado: (2023)

The Efficacy of Radiotherapy without Surgery for External Auditory Canal Squamous Cell Carcinoma
por: Osu, Naoto, et al.
Publicado: (2022)

Prediction of Acute Radiation Mucositis using an Oral Mucosal Dose Surface Model in Carbon Ion Radiotherapy for Head and Neck Tumors
por: Musha, Atsushi, et al.
Publicado: (2015)

Local anesthetic lidocaine-inducible gene, growth differentiation factor-15 suppresses the growth of cancer cell lines
por: Haraguchi-Suzuki, Keiko, et al.
Publicado: (2022)

Actin-binding protein filamin B regulates the cell-surface retention of endothelial sphingosine 1-phosphate receptor 1
por: Zhao, Xian, et al.
Publicado: (2023)

Proton export upregulates aerobic glycolysis
por: Russell, Shonagh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f0fkjjq7rq889dbs73pu2d9v51